The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial
Open accessAbstract
CONTEXT: Hyperuricemia is a predictor for the development of hypertension and is commonly present in new-onset essential hypertension. Experimentally increasing uric acid levels using a uricase inhibitor causes systemic hypertension in animal models. OBJECTIVE: To determine whether lowering uric acid lowers blood pressure (BP) in hyperuricemic adolescents with newly diagnosed hypertension. DESIGN, SETTING, AND PATIENTS: Randomized, double-blind, placebo-controlled, crossover trial (September 2004-March 2007) involving 30 adolescents (aged 11-17 years) who had newly diagnosed, never-treated stage 1 essential hypertension and serum uric acid levels > or = 6 mg/dL. Participants were treated at the Pediatric Hypertension Clinic at Texas Children's Hospital in Houston. Patients were excluded if they had stage 2 hypertension or known renal, cardiovascular, gastrointestinal tract, hepatic, or endocrine disease. INTERVENTION: Allopurinol, 200 mg twice daily for 4 weeks, and placebo, twice daily for 4 weeks, with a 2-week washout period between treatments. The order of the treatments was randomized. MAIN OUTCOME MEASURES: Change in casual and ambulatory blood pressure. RESULTS: For casual BP, the mean change in systolic BP for allopurinol was -6.9 mm Hg (95% confidence interval [CI], -4.5 to -9.3 mm Hg) vs -2.0 mm Hg (95% CI, 0.3 to -4.3 mm Hg; P = .009) for placebo, and the mean change in diastolic BP for allopurinol was -5.1 mm Hg (95% CI, -2.5 to -7.8 mm Hg) vs -2.4 (95% CI, 0.2 to -4.1; P = .05) for placebo. Mean change in mean 24-hour ambulatory systolic BP for allopurinol was -6.3 mm Hg (95% CI, -3.8 to -8.9 mm Hg) vs 0.8 mm Hg (95% CI, 3.4 to -2.9 mm Hg; P = .001) for placebo and mean 24-hour ambulatory diastolic BP for allopurinol was -4.6 mm Hg (-2.4 to -6.8 mm Hg) vs -0.3 mm Hg (95% CI, 2.3 to -2.1 mm Hg; P = .004) for placebo. Twenty of the 30 participants achieved normal BP by casual and ambulatory criteria while taking allopurinol vs 1 participant while taking placebo (P < .001). CONCLUSIONS: In this short-term, crossover study of adolescents with newly diagnosed hypertension, treatment with allopurinol resulted in reduction of BP. The results represent a new potential therapeutic approach, although not a fully developed therapeutic strategy due to potential adverse effects. These preliminary findings require confirmation in larger clinical trials. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00288184.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00027 · Cited by 1,793
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Self-citationOverweight, Ethnicity, and the Prevalence of Hypertension in School-Aged Children
Sorof, J. M., Lai, D., Turner, J., Poffenbarger, T., & Portman, R. J. (2004) · Pediatrics · doi:10.1542/peds.113.3.475 · Cited by 1,075
Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
Cardiovascular protection and blood pressure reduction: a meta-analysis
Staessen, J. A., Wang, J.-G., & Thijs, L. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06411-x · Cited by 944
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826
Self-citationSautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00600.2006 · Cited by 787
Self-citationKanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Self-citationSoergel, M., Kirschstein, M., Busch, C., Danne, T., Gellermann, J., Holl, R., Krull, F., Reichert, H., Reusz, G. S., & Rascher, W. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70340-8 · Cited by 625
George, J., Carr, E., Davies, J., Belch, J. J. F., & Struthers, A. (2006) · Circulation · doi:10.1161/circulationaha.106.651117 · Cited by 569
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity
Watanabe, S., Kang, D.-H., Feng, L., Nakagawa, T., Kanellis, J., Lan, H., Mazzali, M., & Johnson, R. J. (2002) · Hypertension · doi:10.1161/01.hyp.0000028589.66335.aa · Cited by 563
Self-citationHyperuricemia in Childhood Primary Hypertension
Feig, D. I., & Johnson, R. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000085858.66548.59 · Cited by 535
Self-citationHyperuricemia in Primary and Renal Hypertension
Cannon, P. J., Stason, W. B., Demartini, F. E., Sommers, S. C., & Laragh, J. H. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609012750902 · Cited by 505
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence
Sundström, J., Sullivan, L., D’Agostino, R. B., Levy, D., Kannel, W. B., & Vasan, R. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000150784.92944.9a · Cited by 491
SELBY, J. V., FRIEDMAN, G. D., & QUESENBERRY, C. P. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115593 · Cited by 327
Childhood Uric Acid Predicts Adult Blood Pressure: The Bogalusa Heart Study
Alper, A. B., Chen, W., Yau, L., Srinivasan, S. R., Berenson, G. S., & Hamm, L. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000150783.79172.bb · Cited by 314
Uric Acid and the Development of Hypertension: The Normative Aging Study
Perlstein, T. S., Gumieniak, O., Williams, G. H., Sparrow, D., Vokonas, P. S., Gaziano, M., Weiss, S. T., & Litonjua, A. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000248752.08807.4c · Cited by 294
Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome
Krishnan, E., Kwoh, C. K., Schumacher, H. R., & Kuller, L. (2007) · Hypertension · doi:10.1161/01.hyp.0000254480.64564.b6 · Cited by 293
Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?
Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sánchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010063 · Cited by 280
Self-citationUric Acid and Endothelial Dysfunction in Essential Hypertension
Zoccali, C., Maio, R., Mallamaci, F., Sesti, G., & Perticone, F. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090949 · Cited by 241
Mellen, P. B., Bleyer, A. J., Erlinger, T. P., Evans, G. W., Nieto, F. J., Wagenknecht, L. E., Wofford, M. R., & Herrington, D. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000249768.26560.66 · Cited by 235
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk
Mercuro, G., Vitale, C., Cerquetani, E., Zoncu, S., Deidda, M., Fini, M., & Rosano, G. M. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.032 · Cited by 223
Ferreira, A. P., Oliveira, C. E. R., & França, N. M. (2007) · Jornal de Pediatria · doi:10.2223/jped.1562 · Cited by 185
Uric Acid and Diet — Insights into the Epidemic of Cardiovascular Disease
Johnson, R. J., & Rideout, B. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048015 · Cited by 158
Self-citationErdoğan, D., Güllü, H., Caliskan, M., Yıldırım, E., Bilgi, M., Ulus, T., Sezgin, N., & Müderrisoğlu, H. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00621.x · Cited by 145
Effects of acute and chronic l -arginine treatment in experimental hyperuricemia
Sánchez‐Lozada, L. G., Tapia, E., López-Molina, R., Nepomuceno‐Mejía, T., Soto, V., Ávila-Casado, C., Nakagawa, T., Johnson, R. J., Herrera-Acosta, J., & Franco, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00164.2006 · Cited by 139
Self-citationSarafidis, P. A., & Bakris, G. L. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07309.x · Cited by 130
ON CHRONIC BRIGHT'S DISEASE, AND ITS ESSENTIAL SYMPTOMS.
Mahomed, F. A. (1879) · The Lancet · doi:10.1016/s0140-6736(02)45936-3 · Cited by 130
Value of Noninvasive Hemodynamics to Achieve Blood Pressure Control in Hypertensive Subjects
Smith, R. D., Levy, P. J., & Ferrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000209642.11448.e0 · Cited by 116
Serum Uric Acid and the Renin‐Angiotensin System in Hypertension
Saito, I., Saruta, T., Kondo, K., Nakamura, R., Oguro, T., Yamagami, K., Ozawa, Y., & Kato, E. (1978) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1978.tb02396.x · Cited by 95
A Continuous Fluorescence Assay of Renin Activity
Wang, G. T., Chung, C. C., Holzman, T. F., & Krafft, G. A. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1207 · Cited by 84
Greenberg, B., Hermann, D. D., Pranulis, M. F., Lazio, L., & Cloutier, D. A. (2000) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2000.80140.x · Cited by 76
Effects of antihypertensive drugs on blood pressure and proteinuria in childhood
Simonetti, G. D., Rizzi, M., Donadini, R., & Bianchetti, M. G. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282efeb7e · Cited by 57
THE CARDIO-VASCULAR AND RENAL RELATIONS AND MANIFESTATIONS OF GOUT.
Davis, N. S. (1897) · JAMA · doi:10.1001/jama.1897.02440320005001a · Cited by 55
Risk Factors for Cardiovascular Disease: One Down, Many More To Evaluate
Vaccarino, V., & Krumholz, H. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00012 · Cited by 44
Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?
Garrick, R. E. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70445-0 · Cited by 28
ON CHRONIC BRIGHT'S DISEASE, AND ITS ESSENTIAL SYMPTOMS.
Mahomed, F. A. (1879) · The Lancet · doi:10.1016/s0140-6736(02)46030-8 · Cited by 24
Ventura, H. O., Pranulis, M. F., Young, C. B. A., & Smart, F. W. (2000) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2000.80147.x · Cited by 16
Measurement of exercise cardiac output by thoracic impedance in healthy children
Pianosi, P. T. (2004) · European Journal of Applied Physiology · doi:10.1007/s00421-004-1167-5 · Cited by 15
Cited by
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Self-citationJohnson, R. K., Appel, L. J., Brands, M., Howard, B. V., Lefevre, M., Lustig, R. H., Sacks, F., Steffen, L. M., & Wylie-Rosett, J. (2009) · Circulation · doi:10.1161/circulationaha.109.192627 · Cited by 1,207
Self-citationUric acid transport and disease
So, A., & Thorens, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42344 · Cited by 861
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Metadata
- Authors
- Feig, D. I., Soletsky, B., & Johnson, R. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-08-27
- Volume
- 300
- Issue
- 8
- Pages
- 924
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2031005241
- Cited by
- 914
- References
- 43
- FWCI
- 42.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.